PDF
Abstract
Aim: This study aims to investigate the mechanisms by which vascular endothelial cells regulate the immune microenvironment in scleroderma.
Methods: Two public single-cell RNA sequencing (scRNA-seq) datasets (GSE264508 and GSE138669) from the Gene Expression Omnibus (GEO) database were analyzed, including skin samples from localized and systemic scleroderma patients. Seurat was used for data processing and clustering, CellChat for cell communication analysis, Monocle2 for pseudotime analysis, scMetabolism for metabolic profiling, and TwoSampleMR to identify potential causal genes based on expression quantitative trait loci (eQTL) data.
Results: We identified distinct EC subtypes and found enhanced communication between ECs and myeloid cells in scleroderma, indicating an active role in immune regulation. ECs remodeled the immune microenvironment via multiple ligand-receptor pairs. Increased oxidative phosphorylation in early-stage ECs was linked to immune activation. Pseudotime analysis revealed dynamic differentiation, and Mendelian randomization identified COX4I1 as a potential pathogenic and therapeutic target.
Conclusion: This study provides a comprehensive single-cell atlas of ECs in scleroderma, highlighting their immunometabolic plasticity and crosstalk with immune cells. The findings suggest that ECs are active participants in the early pathogenesis of skin fibrosis and support COX4I1 as a potential therapeutic target.
Keywords
Scleroderma
/
endothelial cells
/
single-cell RNA sequencing
/
immunometabolic remodeling
/
cell-cell communication
/
COX4I1
/
mendelian randomization
Cite this article
Download citation ▾
Maxwell Andriano Kishengere, Yayun Li, Yao Lu, Zhanghui Yue.
Endothelial cell heterogeneity and immune-metabolic crosstalk in scleroderma: insights from single-cell RNA sequencing.
Vessel Plus, 2025, 9(1): 22 DOI:10.20517/2574-1209.2025.76
| [1] |
Ferreli C,Parodi A,Rongioletti F.Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review.Clin Rev Allergy Immunol2017;53:306-36
|
| [2] |
Patnaik E,Tran K.Endothelial dysfunction in systemic sclerosis.Int J Mol Sci2023;24:14385 PMCID:PMC10531630
|
| [3] |
Nilforoushzadeh MA,Ghane Y.Efficacy and safety of platelet-rich plasma therapy in systemic sclerosis and localized scleroderma; a systematic review.Arch Dermatol Res2025;317:504
|
| [4] |
Vasquez R,Jacobe H.Morphea and other localized forms of scleroderma.Curr Opin Rheumatol2012;24:685-93
|
| [5] |
McMahan ZH.Systemic sclerosis-challenges for clinical practice.Nat Rev Rheumatol2013;9:90-100
|
| [6] |
Kreuter A.Localized scleroderma.Dermatol Ther2012;25:135-47
|
| [7] |
Florez-Pollack S,Jacobe HT.Morphea: current concepts.Clin Dermatol2018;36:475-86
|
| [8] |
Snarskaya ES.Localized scleroderma: actual insights and new biomarkers.Int J Dermatol2022;61:667-74
|
| [9] |
Allanore Y.Systemic sclerosis: a multisystem disease; time to think beyond scleroderma.Arthritis Rheumatol2025;77:805-7
|
| [10] |
Sun X,Mastikhina O,Nunes SS.Endothelium-mediated contributions to fibrosis.Semin Cell Dev Biol2020;101:78-86
|
| [11] |
Laplante P,Raymond MA.Caspase-3-mediated secretion of connective tissue growth factor by apoptotic endothelial cells promotes fibrosis.Cell Death Differ2010;17:291-303
|
| [12] |
Maurer B,Suliman YA.Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis.Ann Rheum Dis2014;73:1880-7
|
| [13] |
Manetti M,Rosa I.Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.Ann Rheum Dis2017;76:924-34
|
| [14] |
Pérez L,Riedel CA.Endothelial-to-mesenchymal transition: Cytokine-mediated pathways that determine endothelial fibrosis under inflammatory conditions.Cytokine Growth Factor Rev2017;33:41-54
|
| [15] |
Barron L.Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages.Am J Physiol Gastrointest Liver Physiol2011;300:G723-8 PMCID:PMC3302189
|
| [16] |
Kantari-Mimoun C,Klose R.Resolution of liver fibrosis requires myeloid cell-driven sinusoidal angiogenesis.Hepatology2015;61:2042-55
|
| [17] |
Hsu T,Trojanowska M.Active roles of dysfunctional vascular endothelium in fibrosis and cancer.J Biomed Sci2019;26:86 PMCID:PMC6816223
|
| [18] |
Tang PM,Lan HY.Macrophages: versatile players in renal inflammation and fibrosis.Nat Rev Nephrol2019;15:144-58
|
| [19] |
Baci D,Parisi L.Innate immunity effector cells as inflammatory drivers of cardiac fibrosis.Int J Mol Sci2020;21:7165 PMCID:PMC7583949
|
| [20] |
Matsuda M.The liver fibrosis niche: Novel insights into the interplay between fibrosis-composing mesenchymal cells, immune cells, endothelial cells, and extracellular matrix.Food Chem Toxicol2020;143:111556 PMCID:PMC7484466
|
| [21] |
Tsou PS,Amin MA.Histone deacetylase 5 is overexpressed in scleroderma endothelial cells and impairs angiogenesis via repression of proangiogenic factors.Arthritis Rheumatol2016;68:2975-85 PMCID:PMC5125850
|
| [22] |
Zhu H,Liu D.The role of metabolism in the pathogenesis of systemic sclerosis.Metabolism2019;93:44-51
|
| [23] |
Coit P,Mirizio EM,Sawalha AH.DNA methylation patterns in juvenile systemic sclerosis and localized scleroderma.Clin Immunol2021;228:108756 PMCID:PMC8206011
|
| [24] |
Makino T,Etoh M.Down-regulation of microRNA-196a in the sera and involved skin of localized scleroderma patients.Eur J Dermatol2014;24:470-6
|
| [25] |
Wang Y,Kahaleh B.Epigenetic down-regulation of microRNA-126 in scleroderma endothelial cells is associated with impaired responses to VEGF and defective angiogenesis.J Cell Mol Med2021;25:7078-88 PMCID:PMC8278107
|
| [26] |
Butler A,Smibert P,Satija R.Integrating single-cell transcriptomic data across different conditions, technologies, and species.Nat Biotechnol2018;36:411-20 PMCID:PMC6700744
|
| [27] |
Jin S,Zhang L.Inference and analysis of cell-cell communication using CellChat.Nat Commun2021;12:1088 PMCID:PMC7889871
|
| [28] |
Tirosh I,Prakadan SM.Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq.Science2016;352:189-96
|
| [29] |
Stuart T,Hoffman P.Comprehensive integration of single-cell data.Cell2019;177:1888-1902.e21 PMCID:PMC6687398
|
| [30] |
Satija R,Gennert D,Regev A.Spatial reconstruction of single-cell gene expression data.Nat Biotechnol2015;33:495-502 PMCID:PMC4430369
|
| [31] |
Trapnell C,Grimsby J.The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells.Nat Biotechnol2014;32:381-6 PMCID:PMC4122333
|
| [32] |
Wu Y,Ma J.Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level.Cancer Discov2022;12:134-53
|
| [33] |
To S.Macrophages and cadherins in fibrosis and systemic sclerosis.Curr Opin Rheumatol2019;31:582-8
|
| [34] |
Jia H,Li P.Neutrophil extracellular traps license macrophage production of chemokines to facilitate CD8+ T cell infiltration in obstruction-induced renal fibrosis.Protein Cell2025:pwaf020
|
| [35] |
Huang Y,Wang L.Atypical chemokine receptor 1-positive endothelial cells mediate leucocyte infiltration and synergize with secreted frizzled-related protein 2/asporin-positive fibroblasts to promote skin fibrosis in systemic sclerosis.Br J Dermatol2024;191:964-78
|
| [36] |
Laurent P, Lapoirie J, Leleu D, et al.; Fédération Hospitalo-Universitaire ACRONIM and the Centre National de Référence des Maladies Auto-Immunes Systémiques Rares de l’Est et du Sud-Ouest (RESO). Interleukin-1β-activated microvascular endothelial cells promote DC-SIGN-positive alternatively activated macrophages as a mechanism of skin fibrosis in systemic sclerosis.Arthritis Rheumatol2022;74:1013-26
|
| [37] |
Jankauskas SS,Bucala R,Boor P.Evolving complexity of MIF signaling.Cell Signal2019;57:76-88
|
| [38] |
Filippou PS,Constantinidou A.Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target.Oncogene2020;39:2040-54
|
| [39] |
Gan C,Xiang Z.Niclosamide-loaded nanoparticles (Ncl-NPs) reverse pulmonary fibrosis in vivo and in vitro.J Adv Res2023;51:109-20 PMCID:PMC10491968
|
| [40] |
Sun HL,Bian HG,Jin J.Novel insight on GRP/GRPR axis in diseases.Biomed Pharmacother2023;161:114497
|
| [41] |
Russo RC.The chemokine system as a key regulator of pulmonary fibrosis: converging pathways in human idiopathic pulmonary fibrosis (IPF) and the bleomycin-induced lung fibrosis model in mice.Cells2024;13:2058 PMCID:PMC11674266
|
| [42] |
Fu Y,Zhao Y,Mao X.Integrative single-cell and spatial transcriptomics analysis reveals MDK-NCL pathway’s role in shaping the immunosuppressive environment of lung adenocarcinoma.Front Immunol2025;16:1546382 PMCID:PMC12089103
|
| [43] |
Xu C,Liang L.Midkine promotes renal fibrosis by stabilizing C/EBPβ to facilitate endothelial-mesenchymal transition.Commun Biol2024;7:544 PMCID:PMC11076470
|
| [44] |
Sorrelle N,Brekken RA.From top to bottom: midkine and pleiotrophin as emerging players in immune regulation.J Leukoc Biol2017;102:277-86 PMCID:PMC5505752
|
| [45] |
Rius Rigau A,Matei AE.Characterization of Vascular Niche in Systemic Sclerosis by Spatial Proteomics.Circ Res2024;134:875-91
|
| [46] |
Zhang L,Wang TY.Nuclear control of mitochondrial homeostasis and venetoclax efficacy in AML via COX4I1.Adv Sci2025;12:e2404620 PMCID:PMC11809339
|
| [47] |
Xu M,Fan C,Zhang H.Ginsenosides Rb1 and Rg1 protect primary cultured astrocytes against oxygen-glucose deprivation/reoxygenation-induced injury via improving mitochondrial function.Int J Mol Sci2019;20:6086 PMCID:PMC6929005
|
| [48] |
Xie T,Jin Y.CoenzymeQ10-induced activation of AMPK-YAP-OPA1 pathway alleviates atherosclerosis by improving mitochondrial function, inhibiting oxidative stress and promoting energy metabolism.Front Pharmacol2020;11:1034 PMCID:PMC7387644
|
| [49] |
Yu L,Lv J,Wang Z.FABP4-mediated lipid metabolism promotes TNBC progression and breast cancer stem cell activity.Cancer Lett2024;604:217271
|
| [50] |
Qiao Y,Yin L.FABP4 contributes to renal interstitial fibrosis via mediating inflammation and lipid metabolism.Cell Death Dis2019;10:382
|
| [51] |
Wu X,Zhang Z.Adipocyte fatty acid binding protein promotes the onset and progression of liver fibrosis via mediating the crosstalk between liver sinusoidal endothelial cells and hepatic stellate cells.Adv Sci2021;8:e2003721 PMCID:PMC8188197
|
| [52] |
Wu YW,Chang CC.Fatty-acid-binding protein 4 as a novel contributor to mononuclear cell activation and endothelial cell dysfunction in atherosclerosis.Int J Mol Sci2020;21:9245 PMCID:PMC7730098
|
| [53] |
Elmasri H,Yu CW.Endothelial cell-fatty acid binding protein 4 promotes angiogenesis: role of stem cell factor/c-kit pathway.Angiogenesis2012;15:457-68 PMCID:PMC3590918
|
| [54] |
Guo D,Lu Y.FABP4 secreted by M1-polarized macrophages promotes synovitis and angiogenesis to exacerbate rheumatoid arthritis.Bone Res2022;10:45 PMCID:PMC9213409
|
| [55] |
Han L,Wu H.Targeting FABP4 to inhibit AGEs-RAGE/NF-κB signalling effectively ameliorates nucleus pulposus dysfunction and angiogenesis in obesity-related intervertebral disc degeneration.Cell Prolif2025;58:e70021
|